More than that, a few Studies have established TXLNA’s existence and manifestation in hepatocellular carcinoma, renal cell carcinoma, and pancreatic tumor cells [7, 8]. This evidence concerns the gene TXLNA and hereditary clear cell renal cell carcinoma.